Polpharma Biologics, based in Switzerland, is a division of Polpharma Group—one of the largest pharmaceutical companies in Central and Eastern Europe and a top 20 global generic drug manufacturer. The company develops and delivers biosimilars worldwide, overseeing the full value chain to move efficiently from concept to launch. With deep expertise across development, manufacturing, and regulatory strategy, its international team partners with leading CDMOs and commercial organizations to bring high-quality biosimilars to patients in major therapeutic areas. Guided by a clear mission to expand access to biologics, Polpharma Biologics is advancing a robust and growing pipeline.
